The clinical picture of Alzheimer's disease in the decade before diagnosis: Clinical and biomarker trajectories

Journal of Clinical Psychiatry

Volumn 77, Issue 3, 2016, Pages e305-e311

  Ritchie, Karen ^a,b,c   Carrière, Isabelle ^a,b   Berr, Claudine ^a,b   Amieva, Hélène ^d   Dartigues, Jean François ^d   Ancelin, Marie Laure ^a,b   Ritchie, Craig W ^c,e  

^a INSERM U1061   (France)

^b UNIV MONTPELLIER   (France)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d INSERM   (France)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; C REACTIVE PROTEIN; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); BIOLOGICAL MARKER; PEPTIDE FRAGMENT;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CASE CONTROL STUDY; COGNITION; CONTROLLED STUDY; DEPRESSION; FEMALE; FOLLOW UP; HIPPOCAMPUS; HUMAN; ILLNESS TRAJECTORY; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NONPARAMETRIC TEST; PRIORITY JOURNAL; VERBAL FLUENCY; VISUAL MEMORY; WHITE MATTER LESION; BLOOD; CLINICAL TRIAL; COGNITION DISORDERS; COMPLICATION; METABOLISM; MULTICENTER STUDY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PRODROMAL SYMPTOM; WHITE MATTER;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; BIOMARKERS; C-REACTIVE PROTEIN; COGNITION DISORDERS; DEPRESSION; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROIMAGING; PEPTIDE FRAGMENTS; PRODROMAL SYMPTOMS; WHITE MATTER;

EID: 84963517304     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.15m09989     Document Type: Article

References (27)

1. Ritchie K, Carrière I, Ritchie CW, et al. Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ. 2010;341:c3885. doi:10.136/bmj.c385 PubMed
2. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011;10(9):819-828. doi:10.106/S147-42(1)707-2 PubMed
3. Reiman EM, Chen K, Alexander GE, et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc Natl Acad Sci USA. 2004;101(1):284-289. doi:10.1073/pnas.26359310 PubMed
4. Scarmeas N, Habeck CG, Stern Y, et al. APOE genotype and cerebral blood flow in healthy young individuals. JAMA. 2003; 290 (12):1581-1582. doi:10.01/jama290.2.581 PubMed
5. Alexopoulos P, Richter-Schmidinger T, Horn M, et al. Hippocampal volume differences between healthy young apolipoprotein E ϵ2 and ϵ4 carriers. J Alzheimers Dis. 2011;26(2):207-210. PubMed
6. Bateman RJ, Xiong C, Benzinger TLS, et al; Dominantly Inherited Alzheimer Network. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med. 2012;367(9):795-804. doi:10.1056/NEJMoa102753 PubMed
7. Jack CR Jr, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010;9(1):119-128. doi:10.16/S174-42(0)7029-6 PubMed
8. Jack CR Jr, Knopman DS, Jagust WJ, et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12(2):207-216. doi:10.16/S17-44(12)7291-0PubMed
9. The 3C Study Group. Vascular factors and risk of dementia: design of the three city study and baseline characteristics of the study population. Neuroepidemiol. 2003;22(6):316-325. doi:10.159/07920 PubMed
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
11. Maller JJ, Daskalakis ZJ, Fitzgerald PB. Hippocampal volumetrics in depression: the importance of the posterior tail. Hippocampus. 2007;17(11):1023-1027. doi:10.02/hipo.2039 PubMed
12. Ritchie K, Jaussent I, Portet F, et al. Depression in elderly persons subject to childhood maltreatment is not modulated by corpus callosum and hippocampal loss. J Affect Disord. 2012;141(2-3):294-299. doi:10.016/.jad.012.035 PubMed
13. Tzen KY, Yang SY, Chen TF, et al. Plasma Aβ but not tau is related to brain PiB retention in early Alzheimer's disease. ACS Chem Neurosci. 2014;5(9):830-836. doi:10.21/cn501j PubMed
14. Straczek C, Ducimetiere P, Barberger-Gateau P, et al. Higher level of systemic C-reactive protein is independently predictive of coronary heart disease in older community-dwelling adults: the three-city study. J Am Geriatr Soc. 2010;58(1):129-135. doi:10.1/j.1532-41529.0625.x PubMed
15. Radloff L. The CES-D Scale: a self report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385-401. doi:10.17/0142167710306
16. Isaacs B, Kennie AT. The Set Test as an aid to the detection of dementia in old people. Br J Psychiatry. 1973;123(575):467-470. doi:10.192/bjp.123.467 PubMed
17. Benton A. Manuel Pour l'Application du Test de Rétention Visuelle: Applications Cliniques et Expérimentales. Paris, France: Centre de Psychologie Appliquée; 1965.
18. Artero S, Tierney MC, Touchon J, et al. Prediction of transition from cognitive impairment to senile dementia: a prospective, longitudinal study. Acta Psychiatr Scand. 2003;107(5):390-393. doi:10.1034/j.16-0472003.00081.x PubMed
19. Schuff N, Tosun D, Insel PS, et al; Alzheimer's Disease Neuroimaging Initiative. Nonlinear time course of brain volume loss in cognitively normal and impaired elders. Neurobiol Aging. 2012;33(5):845-855. doi:10.16/j.neurbiolaing.207.012 PubMed
20. Amieva H, Le Goff M, Millet X, et al. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Ann Neurol. 2008; 64(5):492-498. doi:10.2/na.21509 PubMed
21. Jack CR Jr, Lowe VJ, Senjem ML, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain. 2008;131(pt 3):665-680. doi:10.93/brain/awm336 PubMed
22. Villemagne VL, Pike KE, Chételat G, et al. Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease. Ann Neurol. 2011; 69 (1):181-192. doi:10.2/na.22248 PubMed
23. Lambert J-C, Schraen-Maschke S, Richard F, et al. Association of plasma amyloid with risk of dementia: the prospective Three-City Study. Neurology. 2009;73(11):847-853. doi:10.12/WNL.b0e381b748 PubMed
24. Schuff N, Woerner N, Boreta L, et al; Alzheimer's Disease Neuroimaging Initiative. MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers. Brain. 2009;132(pt 4):1067-1077. doi:10.93/brain/awp007 PubMed
25. Ferretti MT, Cuello AC. Does a pro-inflammatory process precede Alzheimer's disease and mild cognitive impairment? Curr Alzheimer Res. 2011;8(2):164-174. doi:10.274/1562051725982PubMed
26. Sastre M, Richardson JC, Gentleman SM, et al. Inflammatory risk factors and pathologies associated with Alzheimer's disease. Curr Alzheimer Res. 2011;8(2):132-141. doi:10.214/156720517925062 PubMed
27. Brickman AM, Provenzano FA, Muraskin J, et al. Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch Neurol. 2012;69(12):1621-1627. doi:10.01/archneurol.012.1527 PubMed